Baron Capital, an investment management company, released its Q1 2026 investor letter for the “Baron Asset Fund”. A copy of the letter is available to download here. U.S. equity markets started the ...

Shares of Bio-Techne Corp. slid 5.34% to $44.89 Wednesday, on what proved to be an all-around mixed trading session for the stock market, with the S&P 500 Index rising 0.58% to 7,444.25 and the Dow ...

Life sciences company Bio-Techne (NASDAQ:TECH) fell short of the market’s revenue expectations in Q1 CY2026, with sales ...

Bio-Techne’s first quarter was marked by a negative market reaction, with revenue coming in below Wall Street expectations.

Techne (Nasdaq: TECH) is expected to report Q4 earnings around Aug. 1. Here's what Wall Street wants to see: The 10-second takeaway Comparing the upcoming quarter to the prior-year quarter, average ...

Bio-Techne (NASDAQ:TECH) will release its quarterly earnings report on Wednesday, 2025-11-05. Here's a brief overview for investors ahead of the announcement. Analysts anticipate Bio-Techne to report ...

MINNEAPOLIS (AP) — MINNEAPOLIS (AP) — Techne Corp. (TECH) on Wednesday reported fiscal third-quarter profit of $51 million. The Minneapolis-based company said it had profit of 32 cents per share.

Bio-Techne (NASDAQ:TECH) will release its quarterly earnings report on Wednesday, 2024-10-30. Here's a brief overview for investors ahead of the announcement. Analysts anticipate Bio-Techne to report ...

Don't just count the cash, time it. It takes money to make money. Most investors know that, but with business media so focused on the "how much," very few investors bother to ask, "How fast?" When ...

Bio-Techne Corporation (NASDAQ: TECH), a global provider of life science research tools, analytical instruments, and ...